Related Experiment Video
Updated: Jul 19, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
A Rare Case of Infliximab-Induced Small Vessel Vasculitis With Renal Involvement
1University of Colorado, Aurora, USA.
Abstract:
There are few cases in the literature demonstrating vasculitis induced by tumor necrosis factor-α. There exist even fewer cases of systemic inflammation involving the skin, nerves, and kidneys. Here, we present a novel case of a 27-year-old man with Crohn disease refractory to multiple medications, most recently treated with infliximab. He presented with a 3-week history of non-blanching palpable petechial rash involving his bilateral extremities and right upper extremity as well as lesions with black eschar around his ankles. He was found to have refractory cutaneous small vessel vasculitis, nephrotic range proteinuria, and small fiber neuropathy. This case describes the evaluation and treatment of systemic small vessel vasculitis in the setting of infliximab therapy.
More Related Videos
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
09:43Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology